![Alan C. Herman](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Alan C. Herman
Nessuna posizione attualmente
Storia della carriera di Alan C. Herman
Precedenti posizioni note di Alan C. Herman
Società | Posizione | Inizio | Fine |
---|---|---|---|
Ajinomoto Althea, Inc.
![]() Ajinomoto Althea, Inc. Medical SpecialtiesHealth Technology Ajinomoto Althea, Inc. provides biopharmaceutical contract development and manufacturing services to biotechnology and pharmaceutical companies worldwide. It offers development services in the areas of process development, protein formulation technology, analytical development and validation, and regulatory support. The company was founded by Magda Marquet and Francois Ferre in 1998 and is headquartered in San Diego, CA. | Direttore Tecnico/Scientifico/R&S | 21/01/2010 | 01/04/2011 |
Windrose Analytica, Inc. | Amministratore Delegato | 01/01/2005 | 01/01/2009 |
Fondatore | 01/01/2005 | 01/01/2009 | |
COHERUS BIOSCIENCES, INC. | Direttore Tecnico/Scientifico/R&S | 01/04/2011 | - |
Fondatore | 01/09/2010 | - | |
Windrose Medical Properties Trust
![]() Windrose Medical Properties Trust Real Estate Investment TrustsFinance Windrose Medical Properties Trust operated real estate investment trusts. It provided business planning, design, development, finance and management services to healthcare systems, physician groups, and third party medical property owners. Its portfolio includes medical office buildings, outpatient treatment, diagnostic centers, and ambulatory surgery centers. The company was founded in 2002 and was headquartered in Indianapolis, IN. | Fondatore | - | - |
Presidente | - | - | |
Tercica, Inc.
![]() Tercica, Inc. Pharmaceuticals: MajorHealth Technology The Company's principal activity as a biopharmaceutical company is focused on the development and commercialization of products to improve endocrine health. Its first product, IncrelexTM (mecasermin {rDNA origin} injection), or recombinant human insulin-like growth factor-1 (rhIGF-1), is approved by the FDA for the treatment of severe Primary IGFD. The Company licensed the rights to develop, manufacture and commercialize Increlex from Genentech Inc. | Corporate Officer/Principal | 01/01/2003 | - |
MERCK & CO., INC. | Corporate Officer/Principal | - | - |
Formazione di Alan C. Herman
Duke University | Doctorate Degree |
Indiana University of Pennsylvania | Graduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 9 |
Posizioni
Founder | 3 |
Chief Tech/Sci/R&D Officer | 2 |
Corporate Officer/Principal | 2 |
Settori
Health Technology | 5 |
Consumer Services | 3 |
Finance | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 2 |
---|---|
MERCK & CO., INC. | Health Technology |
COHERUS BIOSCIENCES, INC. | Health Technology |
Aziende private | 4 |
---|---|
Windrose Medical Properties Trust
![]() Windrose Medical Properties Trust Real Estate Investment TrustsFinance Windrose Medical Properties Trust operated real estate investment trusts. It provided business planning, design, development, finance and management services to healthcare systems, physician groups, and third party medical property owners. Its portfolio includes medical office buildings, outpatient treatment, diagnostic centers, and ambulatory surgery centers. The company was founded in 2002 and was headquartered in Indianapolis, IN. | Finance |
Tercica, Inc.
![]() Tercica, Inc. Pharmaceuticals: MajorHealth Technology The Company's principal activity as a biopharmaceutical company is focused on the development and commercialization of products to improve endocrine health. Its first product, IncrelexTM (mecasermin {rDNA origin} injection), or recombinant human insulin-like growth factor-1 (rhIGF-1), is approved by the FDA for the treatment of severe Primary IGFD. The Company licensed the rights to develop, manufacture and commercialize Increlex from Genentech Inc. | Health Technology |
Ajinomoto Althea, Inc.
![]() Ajinomoto Althea, Inc. Medical SpecialtiesHealth Technology Ajinomoto Althea, Inc. provides biopharmaceutical contract development and manufacturing services to biotechnology and pharmaceutical companies worldwide. It offers development services in the areas of process development, protein formulation technology, analytical development and validation, and regulatory support. The company was founded by Magda Marquet and Francois Ferre in 1998 and is headquartered in San Diego, CA. | Health Technology |
Windrose Analytica, Inc. |
- Borsa valori
- Insiders
- Alan C. Herman
- Esperienza